CANNAPHARMARX, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cannapharmarx, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Cannapharmarx, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $188K.
  • Cannapharmarx, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$8.53M, a 3.41% increase from 2021.
  • Cannapharmarx, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$8.83M, a 55.6% increase from 2020.
  • Cannapharmarx, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$19.9M, a 2.74% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $188K +$753K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $5.36M +$7.24M Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$11.7M -$10.3M -729% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q3 2023 -$7.5M -$564K +$749K +57% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$8.24M -$1.88M -$373K -24.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$7.87M -$1.41M +$659K +31.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$8.53M -$3.64M +$3.7M +50.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-09-01
Q3 2022 -$12.2M -$1.31M -$284K -27.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 -$11.9M -$1.51M +$159K +9.55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-17
Q1 2022 -$12.1M -$2.07M -$3.27M -273% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-17
Q4 2021 -$8.83M -$7.34M +$4.21M +36.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-09-01
Q3 2021 -$13M -$1.03M +$1.62M +61.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$14.7M -$1.67M -$193K -13.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-21
Q1 2021 -$14.5M $1.2M +$5.41M Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-21
Q4 2020 -$19.9M -$11.6M -$2.24M -24% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$17.7M -$2.65M +$6.67M +71.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$24.3M -$1.47M -$724K -96.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$23.6M -$4.21M -$3.15M -294% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$20.5M -$9.31M -$7.38M -383% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-14
Q3 2019 -$13.1M -$9.32M -$8.23M -751% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$4.84M -$748K -$678K -961% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 -$4.16M -$1.07M -$1.07M Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-29
Q4 2018 -$3.09M -$1.93M -$1.99M -3043% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-27
Q3 2018 -$1.1M -$1.09M -$1.09M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$4.97K -$70.5K $0 0% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$4.97K $0 +$1.67K Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-14
Q4 2017 -$6.63K $65.5K +$102K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-03
Q3 2017 -$108K $0 +$29.5K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$138K -$70.5K +$169K +70.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-09-14
Q1 2017 -$307K -$1.67K +$694K +99.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-09-14
Q4 2016 -$1M -$36.2K +$4.22M +99.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-04-03
Q3 2016 -$5.22M -$29.5K +$1.68M +98.3% Jul 1, 2016 Sep 30, 2016 10-Q 2018-09-14
Q2 2016 -$6.89M -$240K +$3.89M +94.2% Apr 1, 2016 Jun 30, 2016 10-Q 2018-09-14
Q1 2016 -$10.8M -$696K +$962K +58% Jan 1, 2016 Mar 31, 2016 10-Q 2018-09-14
Q4 2015 -$11.7M -$4.25M -$931K -28.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-09-14
Q3 2015 -$10.8M -$1.71M -$1.23M -256% Jul 1, 2015 Sep 30, 2015 10-Q 2018-09-14
Q2 2015 -$9.58M -$4.13M -$3.97M -2595% Apr 1, 2015 Jun 30, 2015 10-Q 2018-09-14
Q1 2015 -$5.61M -$1.66M -$1.63M -6365% Jan 1, 2015 Mar 31, 2015 10-Q 2018-09-14
Q4 2014 -$3.98M -$3.32M -$3.3M -14830% Oct 1, 2014 Dec 31, 2014 10-K 2018-09-11
Q3 2014 -$680K -$479K -$454K -1804% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$226K -$153K -$129K -536% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$97.2K -$25.6K -$2.75K -12% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$94.4K -$22.2K -$1.36K -6.53% Oct 1, 2013 Dec 31, 2013 10-Q 2015-11-13
Q3 2013 -$93K -$25.2K -$1.89K -8.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 -$91.2K -$24.1K -$6.12K -34% Apr 1, 2013 Jun 30, 2013 10-Q 2014-09-09
Q1 2013 -$85K -$22.9K +$13K +36.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-19
Q4 2012 -$98.1K -$20.9K +$1.2K +5.44% Oct 1, 2012 Dec 31, 2012 10-Q 2014-11-19
Q3 2012 -$99.3K -$23.3K +$3.27K +12.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 -$103K -$18K +$17.5K +49.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$120K -$35.9K -$20.3K -131% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$99.7K -$22.1K +$2.91K +11.6% Oct 1, 2011 Dec 31, 2011 10-Q 2014-11-19
Q3 2011 -$103K -$26.6K +$3.85K +12.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-17
Q2 2011 -$106K -$35.5K -$7.5K -26.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 -$98.9K -$15.6K +$746 +4.57% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q4 2010 -$99.7K -$25K Oct 1, 2010 Dec 31, 2010 10-Q 2013-10-31
Q3 2010 -$30.4K Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 -$27.9K Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-25
Q1 2010 -$16.3K Jan 1, 2010 Mar 31, 2010 10-Q 2011-07-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.